United Medical Equipment Business Solutions Network Positioned to Assist as Widespread Rapid Testing Gains Momentum

March 19, 2021 14:49:20
  • New York City ramps up rapid testing efforts, opens 11 rapid-testing sites; others to follow
  • Mayor notes that low-cost, rapid-testing made available to public is key to accelerating economy’s re-opening
  • UME offers rapid -testing kits, provides products and services essential for curbing pandemic and jumpstarting economic recovery

United Medical Equipment Business Solutions Network (“UME”), a trusted supplier of COVID-19 antigen and antibody testing kits, is offering a key product that could impede the spread of the virus and speed up economic recovery. A top U.S. testing official announced a scale-up in the country’s diagnostic efforts, touting both health and economic benefits of rapid testing outside the lab. New York City is wasting no time to leverage the power of this low-cost, high-impact option as the city has announced the launch of its Forward Rapid-Test Program (https://ibn.fm/RmtcD).

The program will make low-cost rapid testing available to the broader public to support economic recovery by enabling businesses to more safely re-open. The city has initially announced that 11 sites will open with the capacity to conduct more than 5,000 tests every day. Additional locations are planned across the city and other parts of the state in the coming weeks.

State officials have noted that testing will be a key part of New York’s post-pandemic recovery because it will help the state accelerate the re-opening of its economy. Testing sites have been situated throughout the city to encourage and support economic activity while minimizing risks to people’s health.

The widespread rapid testing is being rolled out in other countries too. The UK government is also looking at introducing rapid lateral-flow testing to open the parts of the economy that could not open last year, including night clubs and theaters. “That [rapid testing], in combination with vaccination, will probably be the route forward,” said UK Prime Minister Boris Johnson (https://ibn.fm/r5rYk).

As a company committed to providing essential products and services during the pandemic, UME is a trusted supplier of FDA-approved COVID-19 rapid test kits (https://ibn.fm/48e2i). The rapid test is designed to detect coronavirus antibodies in the bloodstream of infected individuals within 10 minutes, which helps position the company at the core of the strategy to bring both economy and society back to normal. The test can also help identify whether a person has protection against the coronavirus.

Finally, UME also offers a unique mobile solution that involves on-call onsite COVID-19 Rapid Testing Mobile units. These units involve mobile testing specialists and experienced medical staff members who provide onsite COVID-19 rapid testing. Capable of nationwide deployment for extended periods, they are especially beneficial for securing employee safety. With an offering deemed essential during the pandemic, UME is well-positioned as an all-around provider of highly-sought-after products and services that may prove crucial for getting the society and economy back to normal.

For more information, visit the company’s website at www.UnitedMedSolutions.com.

NOTE TO INVESTORS: The latest news and updates relating to United Medical Equipment are available in the company’s newsroom at https://ibn.fm/UnitedMed

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
415.949.5050 Office

BioMedWire is part of the InvestorBrandNetwork.